# Project status and verification log — 18 October 2026

## Current state

**Stage:** local screening-workflow prototype and synthetic evaluation-pipeline tests. This is not a validated narcotics detector, chemical analyser, or operational law-enforcement system.

## Successful and evidenced

- Latest known Python CI run [39096448541](https://github.com/Pui89/Multimodal-Narcotics-Screening-AI/actions/runs/39096448541) passed across Python 3.10, 3.11 and 3.12. It checks software/evaluation behavior, not real-world substance identification.
- Repository includes a local API/dashboard, metric/evaluation utilities, synthetic regression fixtures, data provenance/manifest tooling, group-aware splitting and documentation of human review and abstention.
- The dashboard's sample values are manually entered; image upload is preview-only and does not run a trained vision model.

## Continuing now

- Define a narrow, lawful intended-use task and verify each source's licence, permitted use, provenance, consent and annotation quality.
- Keep pharmaceutical pill-image recognition separate from illicit-narcotics identification. C3PI/RxIMAGE-style pharmaceutical datasets are not evidence of illicit-substance classification.
- Expand tests for missing/conflicting modalities, low confidence, out-of-distribution inputs, malformed records, calibration and abstention to UNKNOWN/human review.
- Design a source-separated, expert-reviewed evaluation protocol before reporting real-world performance.

## Not yet demonstrated

- A legally cleared, representative labelled dataset for the exact screening task.
- A trained detector evaluated on an independent held-out set, with precision/recall, false-positive/false-negative rates and calibration.
- Measured benefit from multimodal fusion or generalization across devices and settings.
- Reliable identification of a chemical substance from an image, or a validated screening robot.

## Next actions

1. Confirm the lawful task, data access permissions, class definitions and qualified ground-truth process.
2. Audit source terms, provenance, duplicate leakage, labels and grouping by physical item/source/capture session.
3. Test fail-closed behavior for missing, noisy, contradictory or unfamiliar sensor inputs; uncertain cases must abstain and go to qualified human review.
4. Evaluate unimodal baselines against fusion only when aligned, representative, lawful data exist.
5. Report per-class precision/recall, confusion matrix, calibration, error cases, dataset limitations and reproducibility details.

## Future

Investigate modality ablations, sensor failure, distribution shift, packaging/lighting/device variation, privacy controls and auditability. Any pilot requires independent expert and legal review, secure data handling, and safeguards against treating an AI score as proof.

## Corrections and boundaries

- A synthetic evaluation report proves only that the evaluation pipeline runs.
- Pharmaceutical pill imagery does not establish illicit-narcotics detection.
- Image appearance alone cannot confirm chemical identity.
- AI outputs must not independently trigger accusation, search, detention or other consequential enforcement actions.
- No validated chemical identification or physical screening-robot capability is claimed.

## Cost and safety boundary

Free/local-first; no paid cloud inference or subscription is required by the plan. Do not collect, commit or publish sensitive case data without authorization. Human review and appropriate confirmatory procedures remain necessary.